secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEYCO GROUP INC (WEYS)
CIK:        0000106532
Form:       8-K
Filed at:   2025-03-12T23:59:59+00:00
Accession:  0001558370-25-002805
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Weyco Group fails Nasdaq independent director rule after director resignation; cure period granted
--------------------------------------------------------------------------------

- Director Robert Feitler resigned Feb 28, 2025, causing non-compliance with Nasdaq Listing Rule 5605(b)(1) requiring majority independent directors.
- Nasdaq notified Weyco on Mar 4, 2025 of non-compliance; cure period extends until earlier of next annual meeting or Feb 28, 2026.
- If next annual meeting is before Aug 27, 2025, compliance must be shown by Aug 27, 2025.
- Company is actively searching for new independent director candidates; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/106532/000155837025002805/0001558370-25-002805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/106532/000155837025002805/weys-20250304x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-002805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer